Intelligence Platform
Patents
Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6211207
Pharmaceutical composition
expired patentUS 6210670
Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin
expired patentUS 6210671
Humanized antibodies reactive with L-selectin
expired patentUS 6210680
Method for the prevention and treatment of chronic venous insufficiency
expired patentUS 6210707
Methods of forming protein-linked lipidic microparticles, and compositions thereof
expired patentUS 6210708
Cationic virosomes as transfer system for genetic material
expired patentUS 6210873
Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
expired patentUS 6210887
Methods for evaluating colon tissue for expression of the DRA (down regulated in adenoma)
expired patentUS 6210913
Modulation of integrin-mediated signal transduction
expired patentUS 6210917
Method for suppressing multiple drug resistance in cancer cells
expired patentUS 6210918
Non-invasive method for detection, diagnosis or prediction of term or pre-term labor
expired patentUS 6211148
Antimicrobial peptides from bovine neutrophis
expired patentUS 6211149
Inhibitors of formation of protease resistant prion protein
expired patentUS 6211154
Ketoheterocyclic inhibitors of factor Xa
expired patentUS 6211165
Methods and compositions for reducing ischemic injury of the heart by administering adenos
expired patentUS 6211168
Methods for preparation and use of 1.alpha.,24 (S)-dihydroxy vitamin D2
expired patentUS 6211183
Selective factor Xa inhibitors
expired patentUS 6211195
CRF antagonistic thiophenopyridines
expired patentUS 6211200
Metal complexes
expired patentUS 6211205
Pharmaceutical composition
expired patentUS 6211355
Radionuclide labeling of vitamin B12 and coenzymes thereof
expired patentUS 6211206
Pharmaceutical composition
expired patentUS 6211215
Heterocyclic compounds, their production and use
expired patentUS 6207170
Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
expired